+49 30 648 35 164 service@chameleon-pharma.com

Our Systematic International Local Partner Company Identification Service

Learn More About CPC Systematic International Local Partner Company Identification

Our Process to Establishing International Business & Market Entry

Learn more about International Market Entry Strategies

Siga las últimas noticias de la industria de la salud de los consumidores, de la farmacia, de los cosméticos, de los complementos alimenticios, de los bienes de consumo, de la venta al por mayor, de la venta al por menor y de la producción. (En inglés)

CPC es un equipo de expertos con una larga experiencia en estrategia y marketing, establecimiento de negocios internacionales, concesión de licencias, fusiones y adquisiciones, regulación, registro, publicaciones, búsqueda de ejecutivos y mucho más. (En inglés)

Los servicios de publicación de CPC son datos analíticos precisos que nos ayudan a proporcionar a nuestros clientes información esencial actualizada y conocimientos profundos sobre las tendencias de la industria farmacéutica y OTC. (En inglés)

En Chameleon Pharma Consulting somos expertos con más de 20 años de experiencia en áreas como Consumer Healthcare, Pharma Rx, Cosmética, Complementos alimenticios, FMCG, Venta al por mayor, Venta al por menor, Producción… (En inglés)

Meet CPC at expopharm Munich 2026: Explore Pharmacy and

Meet Chameleon Pharma Consulting CEO Reiner Christensen at expopharm Munich from 15–17 September 2026. Arrange an individual meeting to discuss pharmacy trends, international market entry, partner identification, and consumer healthcare opportunities....

Mexico’s New Fast-Track Drug & Medical Device Registration

Mexico is reshaping its COFEPRIS registration system with a new abbreviated Reliance pathway for eligible drugs and Medical Devices. With review targets of 45 business days for medicines and CPC Fast-Track registration strategies targeting approximately 10–15 months, the new framework creates important opportunities for faster market entry....

Meet Chameleon Pharma Consulting at CPHI Milan 2026

Meet Chameleon Pharma Consulting CEO Reiner Christensen at CPHI Milan from 6–8 October 2026. Schedule a meeting to discuss international market entry, licensing, partner identification, and growth opportunities for your pharma or consumer healthcare business....

Global E-Pharmacy Market to Reach $357B by 2035: Growth Reshaping OTC Distribution

Global OTC e-commerce is reshaping Consumer Health distribution and market entry. For business development managers, online pharmacy growth creates new partnership opportunities while making channel selection, regulation and digital positioning increasingly important....

Global AMR 2026–2036: Why Non-Antibiotic OTC & Diagnostic Solutions Are a Growth Market

Antimicrobial resistance is opening new opportunities for Women’s Health, Consumer Health and diagnostic companies. The strongest concepts will combine evidence-backed prevention, easy-to-use diagnostics and clear pathways connecting responsible self-care with professional treatment....

CPC Free Expert Webinar: How to Enter and Grow in Latin America’s Healthcare Markets

Explore growth opportunities in Latin America’s pharmaceutical and consumer health markets. Gain actionable insights into market entry, distribution and regulatory pathways, with a focus on Brazil, Mexico and Colombia....

ASEAN – Medical Device Directive: Practical Market Entry Roadmap for MedTech Companies

ASEAN’s medical device market is creating new market entry and partnership opportunities for global MedTech companies. This article explores AMDD, local distributors, and growth opportunities across key ASEAN markets, helping business development managers identify regulatory and expansion priorities. ...

Poland’s Generics Market 2040: Pricing Pressure and Entry Opportunities in Rx & OTC

Poland’s Rx & OTC market is one of the largest and most mature in Central and Eastern Europe, driven by high generics penetration, expanding pharmacy networks, and rising healthcare demand. With steady long-term growth expected through 2040, the market offers attractive opportunities for international companies seeking to enter a cost-conscious yet innovation-oriented healthcare landscape....

Switzerland Consumer Health and Pharma Market Overview: 2040 Growth Outlook

Total pharma and OTC sales are projected to grow from approximately USD 10.56 billion in 2030 to USD 17.8 billion by 2040, representing a CAGR of 5.36%. Market growth is supported by demographic trends...

Turkey OTC Market Development: Consumer Healthcare Trends and Market Outlook to 2040

With more than 85 million consumers, an increase in the self-medication trend, and a projected market size of USD 2.4 billion in 2040, Turkey represents a promising hub for healthcare companies wanting to internationalise....

Global Phytotherapy Market Growth: 5 Demand Trends Reshaping Consumer Healthcare Companies towards 2040

The herbal medicine market is projected to grow towards approximately USD 835.67 billion by 2040, highlighting the long-term potential of the phytotherapy market....

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s large maternal care base continues to support demand for pregnancy supplements and women’s health products. According to INEGI, Mexico registered 1.67 million births in 2024, equal to 47.7 births per 1,000 women of fertile age. This creates regular demand for prenatal vitamins, folic acid, iron, calcium, DHA, and other Food Supplements supporting pregnancy, maternal wellbeing, and postpartum recovery....

Japan Medical Device Market Access: How to Navigate a Large but Complex Regulatory Landscape

Japan’s Medical Device market is currently standing at USD 34.24 billion in 2025 and could reach approximately USD 60.7 billion by 2035. For Medical Device (MedTech) companies, this creates strong opportunities, but regulatory complexity, MAH requirements and reimbursement planning remain critical for market access....

Why South Korea Dominates the Global Aesthetic Medicine Market: Trends, Innovation, and Growth

South Korea’s aesthetic medicine market is projected to reach USD 8,57 billion by 2033, growing at a CAGR of 14.6% between 2026 & 2033. Combined with strong medical tourism inflows and high demand for non-surgical procedures, the country continues to define global standards in aesthetic medicine...

Spain’s Pharmacy Networks: How Distribution Structures Rx & OTC Market Access

Spain’s total pharma sales are expected to reach USD 50,02 billion in 2040, making it a strategic market to enter. However, understanding pharmacy networks is key as they are not just distribution channels, but gatekeepers of market access....